Miconazole
Classification: BATC code: D01AC02, D01AC20
Summary
A large amount of the studies consider treatment of vaginal infections, therefore analyses on sex or gender differences are lacking.
Additional information
Pharmacokinetics and dosing
No difference between men and women has been shown for transdermal absorption in general [1].
Effects
No studies with a clinically relevant sex analysis regarding effects of mikonazol have been found.
Adverse events
No studies with a clinically relevant sex analysis regarding adverse effects of mikonazol have been found.
Reproductive health issues
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Updated: 2020-08-28
Date of litterature search: 2017-02-21
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson